SpectraCure AB (publ)
SPEC
Rank in Stocks
#33077
SpectraCure AB (publ) specializes in oncology, developing innovative cancer... SpectraCure AB (publ) specializes in oncology, developing innovative cancer treatments that harness laser light and photodynamic agents. A cornerstone of their research is the IDOSE software, which powers an interstitial photodynamic therapy (PDT) system. This cutting-edge system is currently in Phase II clinical trials, where its efficacy in addressing solid tumors is being evaluated. The Swedish company, established in Lund in 2003, continues to advance its therapeutic solutions.
Share Price
$0.001561
Last synced: 2026-11-09
Market Cap
$893.21K
Change (1 day)
0.92%
Change (1 year)
-92.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SpectraCure AB (publ) (SPEC)
Category
Healthcare
Operating Margin for SpectraCure AB (publ) (SPEC)
Operating Margin as of November 2026 TTM: 0.00%
According to SpectraCure AB (publ)'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for SpectraCure AB (publ) from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | -6,714.15% | 34.14% |
| 2022 | -5,005.19% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -1,359,620.15% | -27.39% |
| 2019 | -1,872,608.13% | 115,952.29% |
| 2018 | -1,613.59% | -51.95% |
| 2017 | -3,358.37% | -14.81% |
| 2016 | -3,941.99% | 433.62% |
| 2015 | -738.73% | -13.27% |
| 2014 | -851.79% | 126.66% |
| 2013 | -375.80% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | - |
US
|
|
| 18.08% | - |
IE
|
|
| 21.25% | - |
US
|
|
| 21.05% | - |
US
|
|
| 28.09% | - |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SpectraCure AB (publ)'s operating margin
What was SpectraCure AB (publ)'s operating margin in 2025?
In 2025, SpectraCure AB (publ)'s operating margin was 0.00%, compared with 0.00% in 2024.
How has SpectraCure AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, SpectraCure AB (publ)'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-1,359,620.15%).
How does SpectraCure AB (publ)'s operating margin compare with similar companies?
SpectraCure AB (publ)'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.